๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Dasatinib - Medicines in Ireland

33 authorised products containing Dasatinib, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 33 authorised medicines
MedicineActive substanceLicence holderStatus
Dasatinib Accord Healthcare 100 mg film-coated tablets
EU/1/24/1839/017-020
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Accord Healthcare 140 mg film-coated tablets
EU/1/24/1839/021-024
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Accord Healthcare 20 mg film-coated tablets
EU/1/24/1839/001-004
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Accord Healthcare 50 mg film-coated tablet
EU/1/24/1839/005-008
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Accord Healthcare 70 mg film-coated tablets
EU/1/24/1839/009-012
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Accord Healthcare 80 mg film-coated tablets
EU/1/24/1839/013-016
Dasatinib Accord Healthcare S.L.U. โ€”
Dasatinib Clonmel 100 mg film-coated tablets
PA0126/310/004
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 20 mg film-coated tablets
PA0126/310/001
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 50 mg film-coated tablets
PA0126/310/002
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Clonmel 70 mg film-coated tablets
PA0126/310/003
Dasatinib Clonmel Healthcare Ltd Marketed
Dasatinib Krka 100 mg film-coated tablets
PA1347/093/005
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 140 mg film-coated tablets
PA1347/093/006
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 20 mg film-coated tablets
PA1347/093/001
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 50 mg film-coated tablets
PA1347/093/002
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 70 mg film-coated tablets
PA1347/093/003
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 80 mg film-coated tablets
PA1347/093/004
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Teva 100 mg Film-coated Tablets
PA1986/066/004
Dasatinib Teva B.V. Marketed
Dasatinib Teva 20 mg Film-coated Tablets
PA1986/066/001
Dasatinib Teva B.V. Marketed
Dasatinib Teva 50 mg Film-coated Tablets
PA1986/066/002
Dasatinib Teva B.V. Marketed
Dasatinib Teva 70 mg Film-coated Tablets
PA1986/066/003
Dasatinib Teva B.V. Marketed
Mubucho 111 mg film-coated tablets
PA1701/003/006
Dasatinib Zentiva k.s. Not marketed
Mubucho 16 mg film-coated tablets
PA1701/003/001
Dasatinib Zentiva k.s. Marketed
Mubucho 40 mg film-coated tablets
PA1701/003/002
Dasatinib Zentiva k.s. Marketed
Mubucho 55 mg film-coated tablets
PA1701/003/003
Dasatinib Zentiva k.s. Marketed
Mubucho 63 mg film-coated tablets
PA1701/003/004
Dasatinib Zentiva k.s. Not marketed
Mubucho 79 mg film-coated tablets
PA1701/003/005
Dasatinib Zentiva k.s. Marketed
Sprycel 10 mg/mL powder for oral suspension
EU/1/06/363/016
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 100 mg film-coated tablets
EU/1/06/363/010-11
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 140 mg film-coated tablets
EU/1/06/363/014-015
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 20 mg film-coated tablets
EU/1/06/363/1-4-7
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 50 mg film-coated tablet
EU/1/06/363/2-5-8
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 70 mg film-coated tablets
EU/1/06/363/3-6-9
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Sprycel 80 mg film-coated tablets
EU/1/06/363/012-013
Dasatinib Bristol-Myers Squibb Pharma EEIG โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.